WAYNE, Pa.--(BUSINESS WIRE)--Jul. 22, 2014--
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical
devices for critical care and surgery, has announced it has received FDA
510(k) clearance to market its ARROW-Clark™ VectorFlow™ Chronic
Hemodialysis Catheter. Designed by Dr. Timothy Clark, M.D., the
VectorFlowTM Catheter features a symmetrical tip design that
allows ease of placement and sustained high flows with minimal
recirculation.
“Providing clinicians with the ARROW-Clark™ VectorFlow™ Catheter
continues a series of new product introductions that demonstrates our
commitment to enhance patient outcomes and improve ease of use for
clinicians,” said Linda Beneze, President and General Manager, Specialty
Division. “We are proud to add the VectorFlow™ Catheter to our
portfolio.”
The ARROW-Clark™ VectorFlow™ Catheter is the only catheter with an
innovative tip designed to produce a helical, three-dimensional
transition of blood entering and leaving the catheter.1
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,400 people worldwide and serves
healthcare providers in more than 150 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, ARROW-Clark and VectorFlow are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates.
© 2014
Teleflex Incorporated. All rights reserved. MC-000213
References:
1. Clark T, et al. Computational Flow Dynamics and Preclinical
Assessment of a Novel Hemodialysis Catheter.
Seminars in
Dialysis. 2012.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com